Jana Jašprová

460 total citations
17 papers, 370 citations indexed

About

Jana Jašprová is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jana Jašprová has authored 17 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Pediatrics, Perinatology and Child Health and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jana Jašprová's work include Heme Oxygenase-1 and Carbon Monoxide (15 papers), Neonatal Health and Biochemistry (14 papers) and Methemoglobinemia and Tumor Lysis Syndrome (6 papers). Jana Jašprová is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (15 papers), Neonatal Health and Biochemistry (14 papers) and Methemoglobinemia and Tumor Lysis Syndrome (6 papers). Jana Jašprová collaborates with scholars based in Czechia, Italy and United States. Jana Jašprová's co-authors include Libor Vı́tek, Claudio Tiribelli, Lucie Muchová, Andrés F. Muro, Giulia Bortolussi, Simone Vodret, Aleš Dvořák, Jaroslav Zelenka, Iryna Goncharova and Marie Urbanová and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and Scientific Reports.

In The Last Decade

Jana Jašprová

17 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jana Jašprová Czechia 12 229 212 106 33 33 17 370
Youjin Dai China 7 161 0.7× 23 0.1× 24 0.2× 41 1.2× 23 0.7× 9 418
Chong Feng China 6 144 0.6× 17 0.1× 31 0.3× 21 0.6× 14 0.4× 12 319
Kateřina Čížková Czechia 10 90 0.4× 50 0.2× 17 0.2× 11 0.3× 12 0.4× 35 318
Aurélie Catan France 10 110 0.5× 21 0.1× 48 0.5× 32 1.0× 18 0.5× 12 438
Suxin Luo China 11 174 0.8× 15 0.1× 31 0.3× 17 0.5× 11 0.3× 16 404
Xiaowen Bao China 10 166 0.7× 14 0.1× 39 0.4× 37 1.1× 23 0.7× 12 364
Helena Gleissman Sweden 8 117 0.5× 12 0.1× 37 0.3× 13 0.4× 13 0.4× 11 363
Zhaosheng Han United States 7 178 0.8× 12 0.1× 34 0.3× 34 1.0× 37 1.1× 13 325
Bo Yi China 10 182 0.8× 12 0.1× 17 0.2× 44 1.3× 52 1.6× 26 361

Countries citing papers authored by Jana Jašprová

Since Specialization
Citations

This map shows the geographic impact of Jana Jašprová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jana Jašprová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jana Jašprová more than expected).

Fields of papers citing papers by Jana Jašprová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jana Jašprová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jana Jašprová. The network helps show where Jana Jašprová may publish in the future.

Co-authorship network of co-authors of Jana Jašprová

This figure shows the co-authorship network connecting the top 25 collaborators of Jana Jašprová. A scholar is included among the top collaborators of Jana Jašprová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jana Jašprová. Jana Jašprová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Verkade, Henkjan J., Anna Bertolini, Sanne de Wit, et al.. (2021). Potential of therapeutic bile acids in the treatment of neonatal Hyperbilirubinemia. Scientific Reports. 11(1). 11107–11107. 16 indexed citations
2.
Klebermass, Eva‐Maria, Theresa Balber, Markus Mitterhauser, et al.. (2021). Inhibition of Lipid Accumulation in Skeletal Muscle and Liver Cells: A Protective Mechanism of Bilirubin Against Diabetes Mellitus Type 2. Frontiers in Pharmacology. 11. 636533–636533. 9 indexed citations
3.
Lešetický, L., Ivan Jelı́nek, Stanislav Smrček, et al.. (2021). Physico-chemical characterization of bilirubin-10-sulfonate and comparison of its acid–base behavior with unconjugated bilirubin. Scientific Reports. 11(1). 12896–12896. 1 indexed citations
4.
Jašprová, Jana, Aleš Dvořák, Marek Vecka, et al.. (2020). A novel accurate LC-MS/MS method for quantitative determination of Z-lumirubin. Scientific Reports. 10(1). 4411–4411. 13 indexed citations
5.
Vreman, Hendrik J., Stephanie Schulz, Jana Jašprová, et al.. (2019). The effect of light wavelength on in vitro bilirubin photodegradation and photoisomer production. Pediatric Research. 85(6). 865–873. 23 indexed citations
6.
Jašprová, Jana, David Biedermann, Lucie Petrásková, et al.. (2019). Isolated Silymarin Flavonoids Increase Systemic and Hepatic Bilirubin Concentrations and Lower Lipoperoxidation in Mice. Oxidative Medicine and Cellular Longevity. 2019. 1–12. 31 indexed citations
7.
Šmíd, V., Neli Kachamakova‐Trojanowska, Jana Jašprová, et al.. (2018). Heme Oxygenase‐1 May Affect Cell Signalling via Modulation of Ganglioside Composition. Oxidative Medicine and Cellular Longevity. 2018(1). 3845027–3845027. 5 indexed citations
8.
Jašprová, Jana, Sunhee Hwang, Jan Kotek, et al.. (2018). Neuro-inflammatory effects of photodegradative products of bilirubin. Scientific Reports. 8(1). 7444–7444. 28 indexed citations
9.
Jašprová, Jana, Aleš Dvořák, Iva Subhanová, et al.. (2018). Chlorophyll‐Mediated Changes in the Redox Status of Pancreatic Cancer Cells Are Associated with Its Anticancer Effects. Oxidative Medicine and Cellular Longevity. 2018(1). 4069167–4069167. 76 indexed citations
10.
Vodret, Simone, Giulia Bortolussi, Jana Jašprová, Libor Vı́tek, & Andrés F. Muro. (2017). Inflammatory signature of cerebellar neurodegeneration during neonatal hyperbilirubinemia in Ugt1 -/- mouse model. Journal of Neuroinflammation. 14(1). 64–64. 38 indexed citations
11.
Šmíd, V., Katerina Hadrava Vanova, Jana Jašprová, et al.. (2016). Changes in Liver Ganglioside Metabolism in Obstructive Cholestasis – the Role of Oxidative Stress. Folia Biologica. 62(4). 148–159. 6 indexed citations
12.
Jašprová, Jana, et al.. (2016). Bilirubin-induced ER stress contributes to the inflammatory response and apoptosis in neuronal cells. Archives of Toxicology. 91(4). 1847–1858. 41 indexed citations
13.
Bočkor, Luka, Giulia Bortolussi, Simone Vodret, et al.. (2016). Modulation of bilirubin neurotoxicity by the Abcb1 transporter in theUgt1-/-lethal mouse model of neonatal hyperbilirubinemia. Human Molecular Genetics. 26(1). ddw375–ddw375. 15 indexed citations
14.
Jašprová, Jana, Iryna Goncharova, Marie Urbanová, et al.. (2016). The Biological Effects of Bilirubin Photoisomers. PLoS ONE. 11(2). e0148126–e0148126. 31 indexed citations
15.
Goncharova, Iryna, Jana Jašprová, Libor Vı́tek, & Marie Urbanová. (2015). Photo-isomerization and oxidation of bilirubin in mammals is dependent on albumin binding. Analytical Biochemistry. 490. 34–45. 15 indexed citations
16.
Vodret, Simone, Giulia Bortolussi, Jana Jašprová, et al.. (2015). Albumin administration prevents neurological damage and death in a mouse model of severe neonatal hyperbilirubinemia. Scientific Reports. 5(1). 16203–16203. 21 indexed citations
17.
Muchová, Lucie, Jana Jašprová, Tomáš Slanina, et al.. (2015). Xanthene-9-carboxylic acid: A photo-activatable transition-metal-free carbon monoxide-releasing molecule with extraordinary long half-life. Nitric Oxide. 47. S35–S35. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026